24-month follow-up confirms efficacy of NiX-TB regimen for XDR-TB

Almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study showed Thursday.
14 views0 comments

Recent Posts

See All

Tailor-made therapy of multi-resistant tuberculosis

The successful treatment of multidrug-resistant tuberculosis requires clarification in advance as to which antibiotics the pathogens are resistant to. Classic testing in the laboratory is very time-co

WHO TB Treatment Outcome Definitions

The World Health Organization (WHO) held an online consultation on the definitions of drug-resistant tuberculosis (DR-TB) treatment outcomes, on 17–19 November 2020. Read the full report here.

MDR-TB trial 6-month regimen appears effective

A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the r